This tender with title Поставка лекарственного препарата Интерферон бета-1а, раствор для подкожного введения, 44 мкг (12 млн. МЕ) в рамках реализации постановления Правительства Российской Федерации от 26.11.2018 № 1416 «О порядке организации обеспечения лекарственными препаратами лиц, больных гемофилией, муковисцидозом, гипофизарным нанизмом, болезнью Гоше, злокачественными новообразованиями лимфоидной, кроветворной и родственных им тканей, рассеянным склерозом, гемолитико-уремическим синдромом, юношеским артритом с системным началом, мукополисахаридозом I, II и VI типов, апластической анемией неуточненной, наследственным дефицитом факторов II (фибриногена), VII (лабильного), X (Стюарта - Прауэра), лиц после трансплантации органов и (или) тканей, а также о признании утратившими силу некоторых актов Правительства Российской Федерации» -- Supply of the medicinal product Interferon beta-1a, solution for subcutaneous administration, 44 μg (12 million IU) in the framework of the implementation of the Decree of the Government of the Russian Federation dated November 26, 2018 No. 1416 “On the procedure for organizing the provision of medicines to persons with hemophilia, cystic fibrosis, pituitary dwarfism , Gaucher disease, malignant neoplasms of lymphoid, hematopoietic and related tissues, multiple sclerosis, hemolytic uremic syndrome, juvenile arthritis with systemic onset, mucopolysaccharidosis types I, II and VI, unspecified aplastic anemia, hereditary factor II (fibrinogen) deficiency labile), X (Stuart-Prower), persons after organ and (or) tissue transplantation, as well as the recognition as invalid of some acts of the Government of the Russian Federation " has been published on Bidding Source portal dated 25 Aug 2021 for the country of Russia. It has been categorized on Planting and maintenance services of green areas & Pituitary, hypothalamic hormones and analogues & Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.
Supply of the medicinal product Interferon beta-1a, solution for subcutaneous administration, 44 μg (12 million IU) in the framework of the implementation of the Decree of the Government of the Russian Federation dated November 26, 2018 No. 1416 “On the procedure for organizing the provision of medicines to persons with hemophilia, cystic fibrosis, pituitary dwarfism , Gaucher disease, malignant neoplasms of lymphoid, hematopoietic and related tissues, multiple sclerosis, hemolytic uremic syndrome, juvenile arthritis with systemic onset, mucopolysaccharidosis types I, II and VI, unspecified aplastic anemia, hereditary factor II (fibrinogen) deficiency labile), X (Stuart-Prower), persons after organ and (or) tissue transplantation, as well as the recognition as invalid of some acts of the Government of the Russian Federation "
General Information
Supply of the medicinal product Interferon beta-1a, solution for subcutaneous administration, 44 μg (12 million IU) in the framework of the implementation of the Decree of the Government of the Russian Federation dated November 26, 2018 No. 1416 “On the procedure for organizing the provision of medicines to persons with hemophilia, cystic fibrosis, pituitary dwarfism , Gaucher disease, malignant neoplasms of lymphoid, hematopoietic and related tissues, multiple sclerosis, hemolytic uremic syndrome, juvenile arthritis with systemic onset, mucopolysaccharidosis types I, II and VI, unspecified aplastic anemia, hereditary factor II (fibrinogen) deficiency labile), X (Stuart-Prower), persons after organ and (or) tissue transplantation, as well as the recognition as invalid of some acts of the Government of the Russian Federation "
For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now
Or Request a call back now and one of our representatives will contact you. Contact us